Call for African Leaders to Support the Pandemic Fund

The COVID-19 crisis has demonstrated the devastating impact that epidemics and pandemics can have on the health, security, and prosperity of Africans. It has accentuated the need for a New Public Health Order for Africa — championed by the Africa Centres for Disease Control and Prevention (Africa CDC) — not in the least because of the gross global inequities in access to medical tools including vaccines, diagnostics, therapeutics, personal protective equipment, and other lifesaving medical countermeasures and supplies that have played out during this pandemic. The COVID-19 pandemic has also underscored the need for Africa to build more resilient health systems and collaborate across borders to be able to prevent, detect, and respond to emerging health threats while addressing ongoing health priorities. 

African civil society organizations (CSOs) have come together to urge leaders of African governments to pledge their support for the proposed new Pandemic Preparedness Fund at the World Bank and to ensure that the Fund advances the aims of the New Public Health Order for Africa through equitable and multilateral support. If well-resourced, the Fund has the potential to be a transformative new source of financing to advance Africa’s health security and to prevent the next pandemic. 

Read the full letter. If your organization is interested in signing on, please reach out to Hanna

 

Pandemic R&D Agenda for Action: Fostering Innovation to End This Pandemic and Prepare for the Next One

As the world commences the third year of the COVID-19 pandemic, the case for investment in research and development (R&D) for medical countermeasures to prevent and combat emerging global health threats is stronger than ever. Despite tremendous scientific accomplishments in 2020-21, systemic gaps in pandemic-related R&D systems, supply chains, manufacturing, and delivery continue to stymie the roll-out of urgently needed technologies to all people who need them, everywhere, and are prolonging the pandemic.

COVID-19 and its variants have exposed longstanding market and systems failures and fragilities that pose barriers to timely and effective pandemic R&D. Not only do these persistent gaps threaten to undo progress achieved through the scientific breakthroughs, but they also exacerbate entrenched inequalities that leave the most vulnerable and disadvantaged people around the globe without access to lifesaving medical countermeasures and essential health services, and perpetuate gross power imbalances between high- and low-income nations. COVID-19 has also unleashed a multitude of actors in pandemic-related R&D across the innovation spectrum and across the globe, underscoring the growing need for more purposeful alignment, coordination, information-sharing, and transparency.

The world urgently needs a fit-for-purpose, proactive, and resilient pandemic R&D ecosystem. There is broad consensus that R&D is a vital component of building a world better equipped to prevent, prepare for, and respond to pandemic threats. Yet new investments in innovation will fail to meet their promise to save lives, prevent future global health emergencies, and build a healthier, safer world for all unless governments, international institutions, and industry are willing to heed the hard lessons of this pandemic and work together to fix these systemic failures and challenges.

Produced by Global Health Technologies Coalition and Pandemic Action Network with contributions by members of the Pandemic Action Network’s Pandemic Preparedness Working Group, this policy brief calls on world leaders to prioritize action in four key areas to close the critical R&D, manufacturing, and delivery gaps necessary to end the acute COVID-19 crisis and build a more resilient, equitable pandemic R&D ecosystem for the future.

Read the full brief here.

Calling on World Leaders for a Global Summit to End the COVID-19 Pandemic

A global pandemic needs a global plan of attack.

A coalition of 80 global leaders and over 25 organizations across corporate, philanthropic, civil society, advocacy, academic, and health sectors is calling on world leaders attending the United Nations General Assembly to convene a global summit to ignite an urgent global action plan to end the pandemic.

This call-to-action was coordinated by the COVID Collaborative, Duke-Margolis Center for Health Policy, Duke Global Health Innovation Center, Duke Global Health Institute, and the Pandemic Action Network.

Read the full letter to world leaders here.

Call-to-Action to African Leaders: Scale Up COVID-19 Testing Now

As the world looks back on one full year of living in the COVID-19 pandemic, the response is still far from over. With only 41 million tests conducted in Africa since the start of the pandemic, and 28,030 tests conducted per million people (well below the Africa CDC-recommended optimal testing level of 75,000 tests per million people), there is an urgent need for African Union (AU) member states to scale-up testing. In spite of disruptions in the global supply chain for COVID-19 tools, including diagnostics, there has been a slow but steady increase in testing. However, the continent needs a rapid scale up of testing for better epidemiological management of the pandemic in order to keep economies open and save lives. Without sufficient testing, we are fighting the pandemic blindly.

Africa CDC and Partners Working Group on Testing, of which Pandemic Action Network is a member, has developed a letter signed by Center for Global Health Security and Diplomacy, FIND Diagnostics, PSI, Right to Health Action, and WACI Health, and three advocacy networks each composed of 100+ members (Pandemic Action Network, Global Fund Advocacy Network, and Treatment Action Group).

The call-to-action is directed to African Ministers of Health urging them to:

  • Order quality-assured antigen tests  
  • Ensure sufficient budget for procurement of antigen tests and testing this fiscal year
  • Ensure sufficient budget for procurement of lower-priced PCR tests for COVID-19 and other diseases including TB, HIV, and Hepatitis C

Read the call-to-action letter here and contact [email protected] to take part in the advocacy efforts with AU leaders.

Guaranteeing Equitable Access: Considerations During Vaccine Development Impacting Global Access

As world leaders come together to strategize how best to inoculate against, test for, and treat COVID-19 across the world, they must prioritize equity in their agendas to end this pandemic as swiftly as possible. The Pandemic Action Network’s Ending Barriers to Equitable Access Working Group has crafted a briefing with key considerations for decision-makers to ensure vaccines, therapeutics, and diagnostics reach those who need it most, when they need it most. We are all at risk until this disease is defeated internationally. We must ensure that low- and middle-income countries and vulnerable groups have equitable access to the tools needed to fight COVID-19 on every front. Read the full paper here.

Contributors to the paper include Deutsche Stiftung Weltbevölkerung (DSW), Global Citizen, Global Health Technologies Coalition (GHTC), PATH, and VillageReach. Special thank you to DSW for design support.